|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Nebivolol#How Supplied]] |
| {{Nebivolol}}
| |
| {{CMG}}; {{AE}} {{SS}}
| |
| | |
| ==how supplied storage and handling==
| |
| BYSTOLIC is available as tablets for oral administration containing nebivolol hydrochloride equivalent to 2.5, 5, 10, and 20 mg of nebivolol.
| |
| | |
| BYSTOLIC tablets are triangular-shaped, biconvex, unscored, differentiated by color and are engraved with “FL” on one side and the number of mg (2 ½, 5, 10, or 20) on the other side. BYSTOLIC tablets are supplied in the following strengths and package configurations:
| |
| | |
| {|
| |
| |-
| |
| |[[File:Nebivolol05.jpg|thumb|800px]]
| |
| |-
| |
| |}
| |
| '''Store at 20° to 25°C (68° to 77°F) [see USP for Controlled Room Temperature]'''.
| |
| | |
| Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.
| |
| | |
| <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = BYSTOLIC (NEBIVOLOL HYDROCHLORIDE) TABLET [FOREST LABORATORIES, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8b8ad213-1dc8-454e-a524-075685c0e1a8 | publisher = | date = | accessdate = 4 February 2014 }}</ref>
| |
| | |
| | |
| | |
| | |
| | |
| ==References==
| |
| | |
| {{Reflist|2}}
| |
| | |
| [[Category:Beta blockers]]
| |
| | |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |
| {{WikiDoc Help Menu}}
| |
| {{WikiDoc Sources}}
| |